{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:21:26Z","timestamp":1775640086054,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Viral infections and reactivations have been linked to several pregnancy complications. Antiviral medications are often prescribed as a prophylactic measure to prevent infant infection. This study examines associations between antiviral medication use during pregnancy and preeclampsia, thereby exploring links between viruses and such pregnancy complication. We analyzed data from 618,814 first-time mothers in Sweden (2007\u20132019) using four national registers. Of these 27,135 (4.4%) developed preeclampsia and 18,004 (2.9%) filled an antiviral medication prescription. Adjusted logistic regression with inverse probability of treatment weighting was used to evaluate associations between use of antiviral medication and preeclampsia. Antiviral medication use was associated with a reduced likelihood of preeclampsia (aOR 0.88; 95% CI, 0.81\u20130.96). Particularly, antiviral medication use was associated with a reduced likelihood of developing preeclampsia with delivery before 34 weeks gestation (aOR 0.66; 95% CI, 0.48\u20130.92) and preeclampsia with a small for gestational age infant (aOR, 0.74; 95% CI, 0.57\u20130.96). Timing of antiviral prescription filling was also investigated. Antiviral medication use in the third trimester was associated with a reduced likelihood of preeclampsia (aOR 0.77; 95% CI, 0.67\u20130.90), but not when used during the first two trimesters. Our study suggests that viral infections or reactivation might play a role in the etiology of preeclampsia, highlighting the need to further explore viral infections\u2019 role in preeclampsia development.<\/jats:p>","DOI":"10.1038\/s41598-025-09283-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:04:46Z","timestamp":1751382286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of antiviral medications during pregnancy and the likelihood of preeclampsia in a population-based register study"],"prefix":"10.1038","volume":"15","author":[{"given":"Alice","family":"Zancanaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Hesselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Fogdell-Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora Kunovac","family":"Kallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Karin","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Lager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"9283_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee, L. A. et al. The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 27, 148\u2013169 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"9283_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","volume":"371","author":"RL Goldenberg","year":"2008","unstructured":"Goldenberg, R. L., Culhane, J. F., Iams, J. D. & Romero, R. Epidemiology and causes of preterm birth. Lancet 371, 75\u201384 (2008).","journal-title":"Lancet"},{"key":"9283_CR3","doi-asserted-by":"publisher","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","volume":"226","author":"CWG Redman","year":"2022","unstructured":"Redman, C. W. G., Staff, A. C. & Roberts, J. M. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. Am. J. Obstet. Gynecol. 226, S907\u2013S927 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"9283_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341\u2013354 (2021).","journal-title":"Lancet"},{"key":"9283_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","volume":"62","author":"F Lyall","year":"2013","unstructured":"Lyall, F., Robson, S. C. & Bulmer, J. N. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62, 1046\u20131054 (2013).","journal-title":"Hypertension"},{"key":"9283_CR6","doi-asserted-by":"crossref","unstructured":"Powe, C. E., Levine, R. J. & Karumanchi, S. A. Preeclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation 123 (2011).","DOI":"10.1161\/CIRCULATIONAHA.109.853127"},{"key":"9283_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12985-017-0813-6","volume":"14","author":"SA Alshareef","year":"2017","unstructured":"Alshareef, S. A., Eltom, A. M., Nasr, A. M., Hamdan, H. Z. & Adam, I. Rubella, herpes simplex virus type 2 and preeclampsia. Virol. J. 14, 142 (2017).","journal-title":"Virol. J."},{"key":"9283_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41564-020-0711-3","volume":"5","author":"F Gaccioli","year":"2020","unstructured":"Gaccioli, F. et al. Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia. Nat. Microbiol. 5, 901\u2013908 (2020).","journal-title":"Nat. Microbiol."},{"key":"9283_CR9","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.202604","volume":"193","author":"SQ Wei","year":"2021","unstructured":"Wei, S. Q., Bilodeau-Bertrand, M., Liu, S. & Auger, N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 193, E540\u2013E548 (2021).","journal-title":"CMAJ"},{"key":"9283_CR10","doi-asserted-by":"publisher","first-page":"e000465","DOI":"10.1136\/bmjmed-2022-000465","volume":"2","author":"AK \u00d6rtqvist","year":"2023","unstructured":"\u00d6rtqvist, A. K. et al. Association between SARS-CoV-2 infection and newly diagnosed hypertension during pregnancy: prospective, population based cohort study. BMJ Med. 2, e000465 (2023).","journal-title":"BMJ Med."},{"key":"9283_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/bdra.23601","volume":"109","author":"NL Davis","year":"2017","unstructured":"Davis, N. L., King, C. C. & Kourtis A. P. Cytomegalovirus infection in pregnancy. Birth Defects Res. 109, 336\u2013346 (2017).","journal-title":"Birth Defects Res."},{"key":"9283_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","volume":"63","author":"G Mor","year":"2010","unstructured":"Mor, G. & Cardenas, I. Review Article: The immune system in pregnancy: A unique complexity. Am. J. Reprod. Immunol. 63, 425\u2013433 (2010).","journal-title":"Am. J. Reprod. Immunol."},{"key":"9283_CR13","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/S2214-109X(16)30362-X","volume":"5","author":"KJ Looker","year":"2017","unstructured":"Looker, K. J. et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Global Health. 5, e300\u2013e309 (2017).","journal-title":"Lancet Global Health"},{"key":"9283_CR14","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1056\/NEJMra0807633","volume":"361","author":"L Corey","year":"2009","unstructured":"Corey, L. & Wald, A. Maternal and neonatal herpes simplex virus infections. N. Engl. J. Med. 361, 1376\u20131385 (2009).","journal-title":"N. Engl. J. Med."},{"key":"9283_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.semperi.2007.01.003","volume":"31","author":"DW Kimberlin","year":"2007","unstructured":"Kimberlin, D. W. Herpes simplex virus infections of the newborn. Semin. Perinatol. 31, 19\u201325 (2007).","journal-title":"Semin. Perinatol."},{"key":"9283_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/09564624241280734","volume":"36","author":"E Clarke","year":"2025","unstructured":"Clarke, E. et al. Joint British association for sexual health and HIV and Royal college of obstetricians and gynaecologists National UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate (2024 update). Int. J. STD AIDS. 36, 4\u201323 (2025).","journal-title":"Int. J. STD AIDS"},{"key":"9283_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/jdv.20450","volume":"39","author":"R Patel","year":"2025","unstructured":"Patel, R. et al. 2024 European guidelines for the management of genital herpes. J. Eur. Acad. Dermatol. Venereol. 39, 742\u2013758 (2025).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"9283_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","volume":"38","author":"S Cnattingius","year":"2023","unstructured":"Cnattingius, S. et al. The Swedish medical birth register during five decades: Documentation of the content and quality of the register. Eur. J. Epidemiol. 38, 109\u2013120 (2023).","journal-title":"Eur. J. Epidemiol."},{"key":"9283_CR19","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1086\/342966","volume":"186","author":"SK Tyring","year":"2002","unstructured":"Tyring, S. K., Baker, D. & Snowden, W. Valacyclovir for herpes simplex virus infection: Long-Term safety and sustained efficacy after 20 years\u2019 experience with acyclovir. J. Infect. Dis. 186, S40\u2013S46 (2002).","journal-title":"J. Infect. Dis."},{"key":"9283_CR20","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1128\/AAC.38.10.2454","volume":"38","author":"R Saltzman","year":"1994","unstructured":"Saltzman, R., Jurewicz, R. & Boon, R. Safety of Famciclovir in patients with herpes Zoster and genital herpes. Antimicrob. Agents Chemother. 38, 2454\u20132457 (1994).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9283_CR21","first-page":"186","volume":"38","author":"JG Spangler","year":"1994","unstructured":"Spangler, J. G., Kirk, J. K. & Knudson, M. P. Uses and safety of acyclovir in pregnancy. J. Fam Pract. 38, 186\u2013191 (1994).","journal-title":"J. Fam Pract."},{"key":"9283_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jama.2010.1206","volume":"304","author":"B Pasternak","year":"2010","unstructured":"Pasternak, B. & Hviid, A. Use of acyclovir, valacyclovir, and Famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304, 859\u2013866 (2010).","journal-title":"JAMA"},{"key":"9283_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","volume":"85","author":"K Mars\u00e1l","year":"1996","unstructured":"Mars\u00e1l, K. et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 85, 843\u2013848 (1996).","journal-title":"Acta Paediatr."},{"key":"9283_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","volume":"15","author":"NC Chesnaye","year":"2021","unstructured":"Chesnaye, N. C. et al. An introduction to inverse probability of treatment weighting in observational research. Clin. Kidney J. 15, 14\u201320 (2021).","journal-title":"Clin. Kidney J."},{"key":"9283_CR25","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin, P. C. & Stuart, E. A. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat. Med. 34, 3661\u20133679 (2015).","journal-title":"Stat. Med."},{"key":"9283_CR26","unstructured":"Greifer, N. & WeightIt Weighting for Covariate Balance in Observational Studies. (2024)."},{"key":"9283_CR27","unstructured":"Greifer, N. cobalt: Covariate Balance Tables and Plots. (2023)."},{"key":"9283_CR28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/07350015.2016.1247004","volume":"36","author":"JE Pustejovsky","year":"2018","unstructured":"Pustejovsky, J. E. & Tipton, E. Small-Sample methods for Cluster-Robust variance Estimation and hypothesis testing in fixed effects models. J. Bus. Econ. Stat. 36, 672\u2013683 (2018).","journal-title":"J. Bus. Econ. Stat."},{"key":"9283_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren, S. & Groothuis-Oudshoorn, K. Mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1\u201367 (2011).","journal-title":"J. Stat. Softw."},{"key":"9283_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin, D. B. Inference and missing data. Biometrika 63, 581\u2013592 (1976).","journal-title":"Biometrika"},{"key":"9283_CR31","doi-asserted-by":"publisher","first-page":"e13844","DOI":"10.1111\/aji.13844","volume":"91","author":"K Motomura","year":"2024","unstructured":"Motomura, K., Morita, H., Naruse, K., Saito, H. & Matsumoto, K. Implication of viruses in the etiology of preeclampsia. Am. J. Reprod. Immunol. 91, e13844 (2024).","journal-title":"Am. J. Reprod. Immunol."},{"key":"9283_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/fvl.11.21","volume":"6","author":"CM Traylen","year":"2011","unstructured":"Traylen, C. M. et al. Virus reactivation: a panoramic view in human infections. Future Virol. 6, 451\u2013463 (2011).","journal-title":"Future Virol."},{"key":"9283_CR33","doi-asserted-by":"publisher","first-page":"e73047","DOI":"10.1371\/journal.pone.0073047","volume":"8","author":"C Minassian","year":"2013","unstructured":"Minassian, C., Thomas, S. L., Williams, D. J., Campbell, O. & Smeeth, L. Acute maternal infection and risk of Pre-Eclampsia: A Population-Based Case-Control study. PLOS ONE. 8, e73047 (2013).","journal-title":"PLOS ONE"},{"key":"9283_CR34","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/ijms22062921","volume":"22","author":"K Narang","year":"2021","unstructured":"Narang, K., Cheek, E. H., Enninga, E. A. L. & Theiler, R. N. Placental immune responses to viruses: molecular and Histo-Pathologic perspectives. Int. J. Mol. Sci. 22, 2921 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"9283_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon, A. C. et al. The role of inflammation in the pathology of preeclampsia. Clin. Sci. (Lond). 130, 409\u2013419 (2016).","journal-title":"Clin. Sci. (Lond)"},{"key":"9283_CR36","doi-asserted-by":"crossref","unstructured":"Michalczyk, M., Celewicz, A., Celewicz, M., Wo\u017aniakowska-Gondek, P. & Rzepka, R. The Role of Inflammation in the Pathogenesis of Preeclampsia. Mediators Inflamm. e3864941 (2020).","DOI":"10.1155\/2020\/3864941"},{"key":"9283_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/aji.12289","volume":"72","author":"K Racicot","year":"2014","unstructured":"Racicot, K., Kwon, J. Y., Aldo, P., Silasi, M. & Mor, G. Understanding the complexity of the immune system during pregnancy. Am. J. Reprod. Immunol. 72, 107\u2013116 (2014).","journal-title":"Am. J. Reprod. Immunol."},{"key":"9283_CR38","unstructured":"Prescribed medications [Socialstyrelsens statistikdatabas]. Stockholm: Socialstyrelsen. [cited: 2024-06-25] https:\/\/sdb.socialstyrelsen.se\/if_lak\/val.aspx"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09283-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09283-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09283-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:04:51Z","timestamp":1751382291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09283-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9283"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09283-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20809"}}